drugset / Trial / NCT01531309
Pharmacokinetics of AGO178 in Participants With Liver Impairment
Non-randomizedParallel-groupOpen-labelOther
Summary
AGO178 was developed for the treatment of depression. A new formulation is being tested in the present study: a tablet to be placed and dissolved under the tongue (sublingual tablet). The goal of this trial was to study the pharmacokinetics of agomelatine given as sublingual tablet in participants with liver impairment and to compare the results to those of healthy volunteers who receive the same treatment.
Timeline
- Start
- 2011-02-08
- Primary completion
- 2011-09-02
- Completion
- 2011-09-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Agomelatine | Small molecule | 1 mg | Other |
Indications
No indication recorded.